Cencora | COR - Ebit

Aktienkurs
308.19
Täglich Wechseln
-3.20 -1.03%
Monatlich
-5.20%
Jährlich
7.80%
Q2 Prognose
301.59




Ebit Veränderung Datum
Ambu A/S DKK 168M 21M 2025-12
Amplifon EUR 26.28M 39.26M 2025-09
Apollo Hospitals Enterprise Ltd INR 7.46B 228M 2025-12
Avanos Medical USD 24.77M 5.8M 2025-12
Brookdale Senior Living USD 27.38M 82.1M 2025-12
Cencora USD 1.02B 1.09B 2025-12
Coloplast 1.85B 102M 2025-12
Convatec Group USD 262.5M 39.7M 2024-12
Diasorin EUR 56.68M 13.53M 2025-09
Encompass Health USD 283.4M 39.8M 2025-12
Enovis USD 2.44M 559.01M 2025-12
GE HealthCare Technologies USD 878M 124M 2025-12
Gulf Medical Proj AED 30.8M 8.97M 2025-12
Hoya 72.9B 43.4B 2025-12
Med Life RON 40.09M 34.8M 2025-09
Oriola-kd EUR 5.4M 1.2M 2025-12
Pediatrix Medical Group USD 54.67M 19.33M 2025-12
Rede D'or Sao Luiz BRL 2.56B 230.77M 2025-12
Siemens Healthineers EUR 677M 214M 2025-12
Solventum Corp USD 105M 1.58B 2025-12
Sonova Holding CHF 296.8M 156.9M 2025-12
Supermax Corporation Bhd MYR -63.56M 79.6M 2025-12
Veradigm USD -45.47M 70.47M 2022-12
Zimmer Biomet Holdings USD 302.9M 35.4M 2025-12